Article

Nationwide study to focus on Fuchs' endothelial corneal dystrophy

A nationwide study will research the genetics of Fuchs' endothelialcorneal dystrophy (FECD), which afflicts about 1% of the generalpopulation. Twenty-three sites nationwide will collect data fromFECD patients and their family members, in order for researchers tofurther explore the genetic causes of the disease.

A nationwide study will research the genetics of Fuchs' endothelial corneal dystrophy (FECD), which afflicts about 1% of the general population. Twenty-three sites nationwide will collect data from FECD patients and their family members, in order for researchers to explore the genetic causes of the disease further.

"A complex relationship between genes-not a single gene-is responsible for causing FECD," said Sudha Iyengar, PhD, principal investigator and associate professor of epidemiology, biostatistics, genetics, and ophthalmology at Case Western Reserve University School of Medicine, Cleveland. "With this new research initiative, we hope to discover more about the genetic likelihood that would cause an individual to develop the disease."

Investigators from the Vision Research Coordinating Center and the department of epidemiology and biostatistics at University Hospitals of Cleveland and Case Western Reserve University School of Medicine will conduct the study, which is funded by a 5-year grant from the National Eye Institute of the National Institutes of Health. The FECD Genetics Multicenter Study will be headquartered at University Hospitals and Case.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
© 2025 MJH Life Sciences

All rights reserved.